These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34142958)

  • 21. Antibiotic consumption in hospitals during COVID-19 pandemic: a comparative study.
    Hussein RR; Rabie ASI; Bin Shaman M; Shaaban AH; Fahmy AM; Sofy MR; Lattyak EA; Abuelhana A; Naguib IA; Ashour AM; Aldeyab MA
    J Infect Dev Ctries; 2022 Nov; 16(11):1679-1686. PubMed ID: 36449638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort.
    Schons MJ; Caliebe A; Spinner CD; Classen AY; Pilgram L; Ruethrich MM; Rupp J; Nunes de Miranda SM; Römmele C; Vehreschild J; Jensen BE; Vehreschild M; Degenhardt C; Borgmann S; Hower M; Hanses F; Haselberger M; Friedrichs AK;
    Infection; 2022 Apr; 50(2):423-436. PubMed ID: 34625912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights and antimicrobial stewardship opportunities in viral pneumonia: five lung ultrasound cases.
    Antonitsch L; Gallob R; Weidinger G; Kettenbach J
    Wien Klin Wochenschr; 2021 Nov; 133(21-22):1208-1214. PubMed ID: 34605974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a restrictive antibiotic policy on the acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in an endemic region: a before-and-after, propensity-matched cohort study in a Caribbean intensive care unit.
    Le Terrier C; Vinetti M; Bonjean P; Richard R; Jarrige B; Pons B; Madeux B; Piednoir P; Ardisson F; Elie E; Martino F; Valette M; Ollier E; Breurec S; Carles M; Thiéry G
    Crit Care; 2021 Jul; 25(1):261. PubMed ID: 34311760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
    Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
    Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibiotic Stewardship 2.0. Individualization of therapy].
    Pletz MW; Tacconelli E; Welte T
    Internist (Berl); 2017 Jul; 58(7):657-665. PubMed ID: 28573366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of an automatic discontinuation of antibiotics policy: A novel approach to antimicrobial stewardship.
    Bolten BC; Bradford JL; White BN; Heath GW; Sizemore JM; White CE
    Am J Health Syst Pharm; 2019 Sep; 76(Supplement_3):S85-S90. PubMed ID: 31418771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions-a viewpoint of experts.
    De Waele JJ; Schouten J; Beovic B; Tabah A; Leone M
    Intensive Care Med; 2020 Feb; 46(2):236-244. PubMed ID: 32025778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India.
    Lukose L; Kaur G; M MA; Abraham GA; Khera K; Subeesh VK; Castelino RL; Karanth S; Udyavara Kudru C; Varma M; Miraj SS
    Expert Rev Anti Infect Ther; 2024 May; 22(5):333-341. PubMed ID: 38189087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.
    Liu P; Ohl C; Johnson J; Williamson J; Beardsley J; Luther V
    BMC Infect Dis; 2016 Dec; 16(1):751. PubMed ID: 27955625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
    Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
    Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can we back off using antibiotics in the NICU?
    Fleiss N; Hooven TA; Polin RA
    Semin Fetal Neonatal Med; 2021 Jun; 26(3):101217. PubMed ID: 33678550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin and Its Limitations: Why a Biomarker's Best Isn't Good Enough.
    Farooq A; Colón-Franco JM
    J Appl Lab Med; 2019 Jan; 3(4):716-719. PubMed ID: 31639738
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimicrobial Stewardship in Hematological Patients at the intensive care unit: a global cross-sectional survey from the Nine-i Investigators Network.
    Rello J; Sarda C; Mokart D; Arvaniti K; Akova M; Tabah A; Azoulay E;
    Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):385-392. PubMed ID: 31707508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic Practice Change to Curtail Linezolid Use in Pediatric Hospitalized Patients in Hawai'i with Uncomplicated Skin and Soft Tissue Infections.
    Okado C; Teramae T
    Hawaii J Health Soc Welf; 2020 May; 79(5 Suppl 1):87-90. PubMed ID: 32490392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
    Chomba RN; Moeng MS; Lowman W
    S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic therapy in pediatric acute appendicitis: Compliance with local protocol to reduce antibiotic overuse.
    Surlemont J; Lecuelle D; Courbier G; Haraux E; Delforge X
    Arch Pediatr; 2020 Jul; 27(5):261-264. PubMed ID: 32409246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative Review.
    Willems J; Hermans E; Schelstraete P; Depuydt P; De Cock P
    Paediatr Drugs; 2021 Jan; 23(1):39-53. PubMed ID: 33174101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use.
    Schuetz P; Beishuizen A; Broyles M; Ferrer R; Gavazzi G; Gluck EH; González Del Castillo J; Jensen JU; Kanizsai PL; Kwa ALH; Krueger S; Luyt CE; Oppert M; Plebani M; Shlyapnikov SA; Toccafondi G; Townsend J; Welte T; Saeed K
    Clin Chem Lab Med; 2019 Aug; 57(9):1308-1318. PubMed ID: 30721141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.